85 related articles for article (PubMed ID: 32702737)
1. B cell clonal expansion and convergent antibody responses to SARS-CoV-2.
Nielsen SCA; Yang F; Hoh RA; Jackson KJL; Roeltgen K; Lee JY; Rustagi A; Rogers AJ; Powell AE; Kim PS; Wang TT; Pinsky B; Blish CA; Boyd SD
Res Sq; 2020 May; ():. PubMed ID: 32702737
[TBL] [Abstract][Full Text] [Related]
2. Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2.
Nielsen SCA; Yang F; Jackson KJL; Hoh RA; Röltgen K; Stevens B; Lee JY; Rustagi A; Rogers AJ; Powell AE; Najeeb J; Otrelo-Cardoso AR; Yost KE; Daniel B; Chang HY; Satpathy AT; Jardetzky TS; Kim PS; Wang TT; Pinsky BA; Blish CA; Boyd SD
bioRxiv; 2020 Jul; ():. PubMed ID: 32676593
[TBL] [Abstract][Full Text] [Related]
3. Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 Infection.
Zhang Y; Yan Q; Luo K; He P; Hou R; Zhao X; Wang Q; Yi H; Liang H; Deng Y; Hu F; Li F; Liu X; Feng Y; Li P; Qu L; Chen Z; Pan-Hammarström Q; Feng L; Niu X; Chen L
J Virol; 2022 Feb; 96(4):e0160021. PubMed ID: 34878902
[TBL] [Abstract][Full Text] [Related]
4. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
[TBL] [Abstract][Full Text] [Related]
5. Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.
Seydoux E; Homad LJ; MacCamy AJ; Parks KR; Hurlburt NK; Jennewein MF; Akins NR; Stuart AB; Wan YH; Feng J; Whaley RE; Singh S; Boeckh M; Cohen KW; McElrath MJ; Englund JA; Chu HY; Pancera M; McGuire AT; Stamatatos L
Immunity; 2020 Jul; 53(1):98-105.e5. PubMed ID: 32561270
[TBL] [Abstract][Full Text] [Related]
6. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors.
Shomuradova AS; Vagida MS; Sheetikov SA; Zornikova KV; Kiryukhin D; Titov A; Peshkova IO; Khmelevskaya A; Dianov DV; Malasheva M; Shmelev A; Serdyuk Y; Bagaev DV; Pivnyuk A; Shcherbinin DS; Maleeva AV; Shakirova NT; Pilunov A; Malko DB; Khamaganova EG; Biderman B; Ivanov A; Shugay M; Efimov GA
Immunity; 2020 Dec; 53(6):1245-1257.e5. PubMed ID: 33326767
[TBL] [Abstract][Full Text] [Related]
8. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
[TBL] [Abstract][Full Text] [Related]
9. Characterization of B-cell receptor clonality and immunoglobulin gene usage at multiple time points during active SARS-CoV-2 infection.
Arons E; Henry K; Haas C; Gould M; Tsintolas J; Mauter J; Zhou H; Burbelo PD; Cohen JI; Kreitman RJ
J Med Virol; 2023 Oct; 95(10):e29179. PubMed ID: 37877800
[TBL] [Abstract][Full Text] [Related]
10. Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein.
Wang X; Lam JY; Wong WM; Yuen CK; Cai JP; Au SW; Chan JF; To KKW; Kok KH; Yuen KY
mBio; 2020 Oct; 11(5):. PubMed ID: 33082264
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.
Kowitdamrong E; Puthanakit T; Jantarabenjakul W; Prompetchara E; Suchartlikitwong P; Putcharoen O; Hirankarn N
PLoS One; 2020; 15(10):e0240502. PubMed ID: 33035234
[TBL] [Abstract][Full Text] [Related]
12. Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.
Schwarzkopf S; Krawczyk A; Knop D; Klump H; Heinold A; Heinemann FM; Thümmler L; Temme C; Breyer M; Witzke O; Dittmer U; Lenz V; Horn PA; Lindemann M
Emerg Infect Dis; 2021 Jan; 27(1):. PubMed ID: 33058753
[TBL] [Abstract][Full Text] [Related]
13. Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes.
Poran A; Harjanto D; Malloy M; Arieta CM; Rothenberg DA; Lenkala D; van Buuren MM; Addona TA; Rooney MS; Srinivasan L; Gaynor RB
Genome Med; 2020 Aug; 12(1):70. PubMed ID: 32791978
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
15. Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers.
Alharbi SA; Almutairi AZ; Jan AA; Alkhalify AM
Cureus; 2020 Sep; 12(9):e10285. PubMed ID: 33047077
[TBL] [Abstract][Full Text] [Related]
16. [SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].
Erensoy S
Mikrobiyol Bul; 2020 Jul; 54(3):497-509. PubMed ID: 32755524
[TBL] [Abstract][Full Text] [Related]
17. Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS.
Fierz W; Walz B
Front Immunol; 2020; 11():1120. PubMed ID: 32582200
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset.
Figueiredo-Campos P; Blankenhaus B; Mota C; Gomes A; Serrano M; Ariotti S; Costa C; Nunes-Cabaço H; Mendes AM; Gaspar P; Pereira-Santos MC; Rodrigues F; Condeço J; Escoval MA; Santos M; Ramirez M; Melo-Cristino J; Simas JP; Vasconcelos E; Afonso Â; Veldhoen M
Eur J Immunol; 2020 Dec; 50(12):2025-2040. PubMed ID: 33084029
[TBL] [Abstract][Full Text] [Related]
19. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
Schultheiß C; Paschold L; Simnica D; Mohme M; Willscher E; von Wenserski L; Scholz R; Wieters I; Dahlke C; Tolosa E; Sedding DG; Ciesek S; Addo M; Binder M
Immunity; 2020 Aug; 53(2):442-455.e4. PubMed ID: 32668194
[TBL] [Abstract][Full Text] [Related]
20. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.
Malone B; Simovski B; Moliné C; Cheng J; Gheorghe M; Fontenelle H; Vardaxis I; Tennøe S; Malmberg JA; Stratford R; Clancy T
Sci Rep; 2020 Dec; 10(1):22375. PubMed ID: 33361777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
